Abstract PD10-01: Elacestrant alone or in combination with triptorelin in premenopausal women with ER+/HER2- early breast cancer: primary analysis from the phase 2 SOLTI-2104- PremiÈRe trial
Abstract PD10-01: Elacestrant alone or in combination with triptorelin in premenopausal women with ER+/HER2- early breast cancer: primary analysis from the phase 2 SOLTI-2104- PremiÈRe trial
Michele Gaudio, Guillermo Villacampa, Marta Tapia, Stephen J. Aragon et al.
Journal
Clinical Cancer Research
Topics
Advanced Breast Cancer Therapies
article
Abstract PD10-01: Elacestrant alone or in combination with triptorelin in premenopausal women with ER+/HER2- early breast cancer: primary analysis from the phase 2 SOLTI-2104- PremiÈRe trial
Michele Gaudio, Guillermo Villacampa, Marta Tapia, Stephen J. Aragon, Antoni Hurtado, Pilar Menchón Sánchez, Tomás Cortadellas, Meritxell Bellet, M.A. Bergamino, María José Senent Vidal, Esther Sanfeliu, Eduard Mension, J. M. Ferrero-Cafiero, S. Cano-Crespo, Y. Fernández, C. Hernando, M. Alva, T. Pascual, X. González-Farré, A. Prat, M. Cruellas, N. Santos, V. Ortega, P. Tolosa, S. González-Santiago, R. Olivera
article en
Abstract
No abstract available for this paper.
Publication Tag
Clinical Cancer ResearchVol. 32(4_Supplement)
Institutions
Hebron University (PS), Universidad de Salamanca (ES), Breast Cancer Research Foundation (US), Universitat Internacional de Catalunya (ES), Research Institute Hospital 12 de Octubre (ES), Hospital Clínico Universitario de Valencia (ES), Instituto Oncológico Dr. Rosell (ES), Hospital Universitario Dexeus (ES), Valencian Infertility Institute (ES), Vall d'Hebron Institut de Recerca (ES), Hospital San Pedro de Alcántara (ES), Hospital General de Catalunya (ES), Vall d'Hebron Hospital Universitari (ES), Hospital Universitario Central de Asturias (ES), Hospital Clínico Universitario Lozano Blesa (ES), Centro de Investigación del Cáncer (ES), Hospital Universitario Virgen de la Arrixaca (ES)